Back to CERS Stock Lookup

Cerus Corp (CERS) – Press Releases

Feb 27, 2015 08:30 AM Cerus Signs INTERCEPT Platelet Agreement With Sweden’s Largest Blood Product Supplier
Feb 26, 2015 04:01 PM Cerus Corporation Reports Fourth Quarter and Year-End 2014 Results
Feb 24, 2015 08:30 AM Cerus to Present at the Cowen and Company 35th Annual Health Care Conference on March 3, 2015
Feb 13, 2015 08:30 AM Cerus to Release Fourth Quarter 2014 Results on February 26, 2015
Feb 5, 2015 08:30 AM Cerus and SunCoast Blood Bank Enter Into Agreement for the Use of INTERCEPT Platelets and Plasma
Feb 4, 2015 08:30 AM Cerus and Blood Bank of Delmarva Enter into Agreement for the Use of INTERCEPT Platelets and Plasma
Jan 28, 2015 08:00 AM Ash Stevens to Manufacture Amotosalen Active Pharmaceutical Ingredient for Cerus' INTERCEPT Blood System
Jan 7, 2015 08:00 AM Cerus Prices $70.0 Million Public Offering of Common Stock
Jan 5, 2015 04:01 PM Cerus Announces Proposed Public Offering of Common Stock
Jan 5, 2015 07:45 AM Cerus Reports EU Phase 3 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint
Dec 22, 2014 08:30 AM Cerus Reports US Phase 2 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint
Dec 18, 2014 07:20 PM FDA Approves INTERCEPT Blood System for Platelets
Dec 16, 2014 05:31 PM FDA Approves INTERCEPT Blood System for Plasma

Back to CERS Stock Lookup